You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SCH 900475

Showing 1 - 25 of 319
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Completed
Has Results
  • Non-small Cell Lung Carcinoma
  • Pembrolizumab
  • +7 more
  • (no location specified)
Oct 13, 2022

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (other, biological, procedure)

Active, not recruiting
Has Results
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,

Active, not recruiting
  • Cancer of Head and Neck
  • +5 more
  • MK-3475 (neoadjuvant)
  • +6 more
  • Boston, Massachusetts
  • +2 more
Dec 9, 2022

Lung Non-Small Cell Carcinoma Trial in Buffalo (Pembrolizumab)

Active, not recruiting
  • Lung Non-Small Cell Carcinoma
  • Pembrolizumab
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 27, 2023

Recurrent Glioblastoma Trial in Houston (Pembrolizumab, Exablate MRgFUS + neoadjuvant pembolizumab)

Not yet recruiting
  • Recurrent Glioblastoma
  • Houston, Texas
    M D Anderson Cancer Center
May 18, 2023

Follicular Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Seattle (Laboratory Biomarker

Active, not recruiting
Has Results
  • Follicular Lymphoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 6, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Terminated
Has Results
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2022

Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial in Chicago

Terminated
Has Results
  • Pancreatic Adenocarcinoma
  • +2 more
  • Pembrolizumab
  • Wild-type Reovirus
  • Chicago, Illinois
    Northwestern University
Sep 6, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Melanoma Trial in Houston (APX005M, Pembrolizumab)

Recruiting
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Bone
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 4, 2023

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 3, 2023

Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

Recruiting
  • Colorectal Neoplasms
  • Microsatellite Instability
  • temozolomide (induction),
  • pembrolizumab (treatment)
  • Milano, Italy
  • +3 more
Sep 28, 2022

Thymoma, Thymic Cancer Trial in Houston (Pembrolizumab)

Recruiting
  • Stage III Thymoma AJCC v8
  • +6 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 31, 2022

Hodgkin's Lymphoma Trial in Seattle (Pembrolizumab, Umbralisib)

Terminated
  • Hodgkin's Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 22, 2022

Triple Negative Breast Cancer Trial in New York (Merck 3475 Pembrolizumab, Intraoperative radiation therapy (IORT))

Recruiting
  • Triple Negative Breast Cancer
  • Merck 3475 Pembrolizumab
  • Intraoperative radiation therapy (IORT)
  • New York, New York
    Columbia University Irving Medical Center
Oct 10, 2022

High Risk Myelodysplastic Syndrome, IPSS Risk Category Intermediate-1, Myelodysplastic Syndrome Trial in Houston (Azacitidine,

Active, not recruiting
Has Results
  • High Risk Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Locally Advanced Malignant Solid Tumor Trial in Houston (Pembrolizumab)

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Mar 22, 2022

Stage I Bladder Cancer AJCC v8, Stage II Bladder Cancer AJCC v8, Stage III Bladder Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Stage I Bladder Cancer AJCC v8
  • +4 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle

Terminated
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • Cabozantinib S-malate
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

Advanced Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Castration-Resistant Prostate Carcinoma, Hormone-Resistant Prostate Cancer, PSA Progression Trial in Portland (drug, other,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 26, 2022